Can the daily position of bolus material influence radiotherapy treatment?
Abstract
Background: Daily bolus positioning implies a high degree of variability, which can affect the dose distribution within the planning target volume (PTV) and the organs at risk (OAR). We carried out a retrospective study to evaluate bolus positioning in patients with breast cancer.
Materials and methods: We evaluated 7 cases with left and 5 cases with right chest-wall with comprehensive nodal region irradiation in which bolus material was used to obtain better skin surface coverage. The bolus positioning on the daily cone-beam computed tomography images was compared to the reference image from the treatment planning system. Deviations from the reference position of the bolus were categorized as positive shifts (PosS) or negative shifts (NegS), depending on the material’s overlapping with its planned position. Subsequently, a second plan was calculated using the information from the CBCT images for comparison with the original treatment plan. We performed a statistical and dosimetric analysis on the results.
Results: For both the 95% dose coverage for the PTV for the chest wall and for the lymph node regions, about 2% variation between initial and recalculated plans was seen, with a shift of the hotspots’ position in some cases. The average mean heart dose was 4.1 ± 0.3 Gy, whereas the values for PosS and NegS mean heart doses were 3.8 ± 0.4 Gy and 4.0 ± 0.6 Gy, respectively. In contrast to the original values for the ipsilateral lung V5 (57.1 ± 12.9%), V20 (30.2 ± 2.7%), and Dmean (15.0 ± 1.7 Gy), the values for PosS were 56.1 ± 4.2% for V5:, 30.1 ± 3.3% for V20, and 14.9 ± 1.2 Gy for Dmean while for NegS we obtained 56.9 ± 8.9% for V5, 30.0 ± 2.3% for V20, and 15.2 ± 1.8 Gy for Dmean.
Conclusion: We observed dosimetric differences between the initial and given treatment plans depending on the position of the bolus for all cases, indifferent of the shift direction. Although the differences were not statistically significant, we identified a few specific instances where the variations might cause uncertainties regarding doses to the OAR. We suggest therefore that strategies for correct daily reproducibility of the bolus need to be implemented on a departmental level.
Keywords: bolus materialbreast cancerpositioningradiotherapy
References
- World Health Organization. Breast Cancer [Internet]. World Health Organization. 2024. https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
- Statistics at a glance, 2022 Top 5 most frequent cancers 2022. https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf.
- Christiansen P, Carstensen SL, Ejlertsen B, et al. Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol. 2018; 57(1): 19–25.
- Perrucci E, Marcantonini M, Arena E, et al. Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction. Rep Pract Oncol Radiother. 2023; 28(1): 1–8.
- Chen Z, Xu Lu, Shi W, et al. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990-2017. Breast Cancer Res Treat. 2020; 180(2): 481–490.
- Bartholomew K, Ghafel M, Tin Tin S, et al. Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences. BMC Cancer. 2023; 23(1): 766.
- Remick J, Amin NP. Postmastectomy Breast Cancer Radiation Therapy. [Updated 2023 Jan 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK519034/.
- Dahn HM, Boersma LJ, de Ruysscher D, et al. The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. Crit Rev Oncol Hematol. 2021; 163: 103391.
- Halperin EC. Perez and Brady's Principles and Practice of Radiation Oncology. 6th ed. Wolters Kluwer/Lippincott Williams & Wilkins 2013: Wilkins.
- Aras S, Tanzer İO, İkizceli T. Dosimetric Comparison of Superflab and Specially Prepared Bolus Materials Used in Radiotherapy Practice. Eur J Breast Health. 2020; 16(3): 167–170.
- Aras S, Tanzer İO, İkizceli T. Dosimetric Comparison of Superflab and Specially Prepared Bolus Materials Used in Radiotherapy Practice. Eur J Breast Health. 2020; 16(3): 167–170.
- Sekartaji G, Aisyah S, Carina C, et al. Comparison of Dosimetry Characteristics from Some Bolus Materials for 6 and 10 MV Photons Beam Radiation Therapy. J Phys Conf Ser. 2020; 1505(1): 012028.
- Kaidar-Person O, Dahn HM, Nichol AM, et al. A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer. Radiother Oncol. 2021; 164: 115–121.
- Nichol A, Narinesingh D, Raman S, et al. The Effect of Bolus on Local Control for Patients Treated With Mastectomy and Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021; 110(5): 1360–1369.
- Leech M, Coffey M, Mast M, et al. ESTRO ACROP guidelines for positioning, immobilisation and position verification of head and neck patients for radiation therapists. Tech Innov Patient Support Radiat Oncol. 2017; 1: 1–7.
- Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015; 114(1): 3–10.
- Meattini I, Becherini C, Boersma L, et al. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022; 23(1): e21–e31.